Acute necrotizing myopathy of intensive care: Electrophysiological studies
暂无分享,去创建一个
[1] S. Ludwin,et al. A Syndrome of Acute Severe Muscle Necrosis in Intensive Care Unit Patients , 1993, Journal of neuropathology and experimental neurology.
[2] D. Lacomis,et al. Acute myopathy and neuropathy in status asthmaticus: Case report and literature review , 1993, Muscle & nerve.
[3] R. Sufit,et al. Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium , 1992, Neuromuscular Disorders.
[4] C. Minetti,et al. Acute quadriplegic myopathy , 1992, Neurology.
[5] R. Massa,et al. Loss and renewal of thick myofilaments in glucocorticoid‐treated rat soleus after denervation and reinnervation , 1992, Muscle & nerve.
[6] R D Miller,et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. , 1992, The New England journal of medicine.
[7] R. Schellens,et al. Critical illness polyneuromyopathy after artificial respiration , 1991, Clinical Neurology and Neurosurgery.
[8] S. Carpenter,et al. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment , 1991, Muscle & nerve.
[9] Prolonged paralysis after treatment with neuromuscular junction blocking agents , 1991, Critical care medicine.
[10] D. Reid,et al. Complete ophthalmoplegia as a complication of acute corticosteroid‐ and pancuronium‐associated myopathy , 1991, Neurology.
[11] W. Sibbald,et al. Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.
[12] R. Miller,et al. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. , 1990, Anesthesiology.
[13] Ronald D. Miller,et al. S THE INDEPENDENT MEASUREMENT OF 3-DESACETYLVECU RONIUM INFLUENCE THE PHARMACOKINETICS OF VECURONIUM? , 1988 .
[14] C. Bolton,et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.
[15] H. Laak,et al. Neuromuscular complications in patients given pavulon/sr (pancuronium bromide) during artificial ventilation , 1985, Clinical Neurology and Neurosurgery.
[16] W. Sibbald,et al. Polyneuropathy in critically ill patients. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[17] Ronald D. Miller. Vecuronium: A New Nondepolarizing Neuromuscular‐Blocking Agent; Clinical Pharmacology, Pharmacokinetics, Cardiovascular Effects and Use in Special Clinical Situations , 1984, Pharmacotherapy.
[18] I. G. Marshall,et al. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. , 1983, British journal of anaesthesia.